X
TGTX icon

Xponance’s TG Therapeutics TGTX Stock Holding History

Xponance’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$454K Buy
13,679
+2,161
+19% +$64.4K ﹤0.01% 1059
2025
Q4 		$343K Buy
11,518
+99
+0.9% +$3.23K ﹤0.01% 1108
2025
Q3 		$413K Buy
11,419
+74
+0.7% +$2.44K ﹤0.01% 1035
2025
Q2 		$408K Buy
11,345
+484
+4% +$18K ﹤0.01% 1027
2025
Q1 		$428K Buy
10,861
+543
+5% +$18.3K ﹤0.01% 983
2024
Q4 		$311K Buy
10,318
+1,326
+15% +$38.1K ﹤0.01% 1118
2024
Q3 		$210K Buy
+8,992
New +$196K ﹤0.01% 1236
2021
Q4 		– Sell
-6,021
Closed -$200K – 1196
2021
Q3 		$200K Sell
6,021
-997
-14% -$30.8K ﹤0.01% 1120
2021
Q2 		$272K Buy
+7,018
New +$276K 0.01% 1096

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return